Related Experiment Video

Updated: Jul 15, 2026

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
06:41

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease

Xi Chen1, Shi Du Yan

  • 1Department of Neurology and Veteran Administration Medical Center, School of Medicine, Saint Louis University, St. Louis, Missouri, USA.

IUBMB Life
|April 12, 2007
PubMed

Insights

Alzheimer's disease (AD) involves mitochondrial dysfunction. Amyloid beta peptide (Abeta) accumulates in mitochondria, causing toxicity and exacerbating stress via interaction with enzymes like ABAD, contributing to AD pathogenesis.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Mitochondrial dysfunction is a hallmark of Alzheimer's disease (AD).
  • The precise mechanisms underlying mitochondrial deficits in AD are not fully understood.
  • Amyloid beta peptide (Abeta) has been found within the mitochondrial matrix in AD brains.

Purpose of the Study:

  • To investigate the role of amyloid beta peptide (Abeta) accumulation in mitochondrial dysfunction in Alzheimer's disease (AD).
  • To elucidate the mechanisms by which mitochondrial Abeta contributes to neurodegeneration.

Main Methods:

  • Analysis of Abeta presence in mitochondria from AD brains and transgenic AD mouse models.
  • Investigation of the interaction between mitochondrial Abeta and the enzyme amyloid beta binding alcohol dehydrogenase (ABAD).
  • Assessment of mitochondrial stress markers, including reactive oxygen species (ROS) and metabolic pathway alterations.

Main Results:

  • Abeta was found to accumulate progressively within mitochondria in AD brains and AD mouse models.
  • Mitochondrial Abeta interacts with ABAD, inhibiting its activity and increasing oxidative stress.
  • This interaction disrupts key metabolic pathways, including glycolysis, the Krebs cycle, and the respiratory chain, leading to the accumulation of toxic metabolites.

Conclusions:

  • Mitochondrial Abeta accumulation and its interaction with ABAD are significant contributors to mitochondrial dysfunction in Alzheimer's disease.
  • These molecular events promote oxidative stress and metabolic disruption, playing a crucial role in AD pathogenesis.
  • Targeting mitochondrial Abeta or its interactions may offer therapeutic strategies for Alzheimer's disease.

More Related Videos

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models08:48

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils15:04

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...